Greek medical cannabis patients report improved quality of life and symptoms in a 2023 survey, but results do not prove causality; larger studies are needed.
Discover how purified CBD helps epilepsy syndromes like Dravet and Lennox-Gastaut, with FDA-approved Epidiolex - yet many cannabis products aren't the answer.
Discover how the USDA repurposes a backpack vacuum into a precise hemp pollen collector, accelerating breeding, germplasm conservation, and hemp genetics.
New study links medical cannabis laws to lower individual-market health insurance premiums years after adoption, exploring potential savings and limits.
CBD searches surge in the U.S., signaling rising public interest and safety questions—discover what the data imply and why stronger labeling matters.
Cannabis exposure linked to lower odds of type 2 diabetes in a 2023 review, but no proven cause-and-effect; more rigorous studies are needed.
Intramuscular cannabinoids may hint at pain relief for acute postoperative pain, but evidence is limited and nonoral routes need more rigorous trials.
Explore what research reveals about cannabis vaping: potency, lung risks, and how to choose safer, regulated products without misleading claims.
Vancouver study hints cannabis may reduce self-reported opioid use as harm-reduction, but it's not a proven substitute for evidence-based treatments.
Canadian study hints off-duty cannabis use isnt tied to more injuries, but impairment around shifts matters; shape policies on fitness for duty.